Connect with us

Health

Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells

Published

on

Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells

NEWYou can now listen to Fox News articles!

A potentially deadly fungus known as “pharaoh’s curse fungus” could offer an unexpected path to fighting cancer, recent research shows.

Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties.

“Fungi gave us penicillin,” said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. “These results show that many more medicines derived from natural products remain to be found.”

SINGLE DOSE OF ‘MAGIC MUSHROOMS’ PROVIDES 5 YEARS OF DEPRESSION RELIEF, RESEARCHERS FIND

Advertisement

The findings were published in the journal Nature Chemical Biology.

Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic.

A sample of Aspergillus flavus cultured in the Gao Lab at the University of Pennsylvania. (Bella Ciervo / UPenn)

While the fungus doesn’t endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications.

Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated.

Advertisement

History of the ‘curse’

After archaeologists opened King Tut’s tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a “curse” upon those who dared interfere with the pharaoh’s rest, according to the UPenn press release.

After archaeologists opened King Tut’s tomb in the 1920s, members of the excavation team died suddenly, fueling rumors of a “curse” upon those who disturbed the pharaoh’s rest. (Historica Graphica Collection/Heritage Images/Getty Images)

Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team.

In the 1970s, it happened again, the university stated. 

A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb.

Advertisement

Cancer-fighting potential

Now, the same fungus linked to King Tut’s tomb could have the capability to fight leukemia in a new form of cancer therapy.

“There are a variety of compounds able to be produced by fungus,” Gao told Fox News Digital.

These compounds can be toxic to different cells, she noted, depending on the “biological management we are able to mitigate.”

CANCER COULD BE DETECTED THREE YEARS BEFORE DIAGNOSIS WITH EXPERIMENTAL BLOOD TEST

The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or “RiPPs” — within Aspergillus flavus, which was previously shown to be a good source.

Advertisement

When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth.

“Cancer cells divide uncontrollably,” Gao said in the release. “These compounds block the formation of microtubules, which are essential for cell division.”

First author Qiuyue Nie and coauthor Maria Zotova, from left, purify samples of the fungus in the UPenn lab. (Bella Ciervo / UPenn)

When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found.

Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin).

Advertisement

Potential limitations

Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages.

YOUR FAVORITE ALCOHOLIC BEVERAGE COULD BE LINKED TO DEADLY FORM OF CANCER, STUDY FINDS

“It’s still very far away from being applicable to use in humans with leukemia,” Troso-Sandoval, who was not involved in the study, told Fox News Digital.

Speaking about RiPPs, the doctor told Fox News Digital, “What they’re referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus.”

Advertisement

There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms.

“One treatment might not work on [another] type of leukemia,” she noted. Further testing is needed to determine which subtypes may contain the active molecule.

Acute myeloid leukemia (AML) is a type of blood cancer. Once the identified compound is able to enter cancer cells, it may be able to stop their uncontrolled growth, the researchers said. (iStock)

The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted.

This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Looking ahead, the researchers plan to test the fungus’ potential in animal models and, ultimately, human trials.

Gao told Fox News Digital she is “excited about what nature can create and how it can benefit our society.”

For more Health articles, visit www.foxnews.com/health

The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.

Advertisement

Health

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

Published

on

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

NEWYou can now listen to Fox News articles!

An accidental lab discovery has opened the door to entirely new ways of preventing the flu.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells, SWNS reported.

By targeting the specific molecules the viruses rely on, scientists found that they could block them from entering new cells and halt their replication altogether.

5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS

Advertisement

Researchers say these “fundamental insights” into seasonal influenza highlight a clear path toward developing better preventive medications.

“The hope is that fundamental, curiosity-based research like this helps to pave the way for novel strategies to treat and prevent influenza infections,” principal investigator Dr. Emily Bruce, from the University of Vermont’s Larner College of Medicine, said in the SWNS report.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells. (iStock)

While several flu strains cause illness, H1N1 and H3N2 influenza A viruses are the most common. However, current flu tests cannot differentiate between them, and clinical treatments are identical for both.

Although vaccines and antivirals are available, Bruce noted a “dire” need for better medications to stop the virus from spreading cell to xxcell.

Advertisement

“You don’t get sick when a virus is in one cell,” he noted. “You get sick because a virus replicates itself and goes into many more cells.”

HOW LONG YOU’RE CONTAGIOUS WITH THE FLU — AND WHEN IT’S SAFE TO GO OUT

The study, which was published in The Journal of Virology, originally aimed to map how viral RNA segments are transported within cells to create new viral particles.

The team used H1N1 and H3N2 viruses isolated from the nasal passages of positive patients in 2022.

Clinical treatments remain identical for both primary strains of the flu virus. (iStock)

Advertisement

During the investigation, the team unexpectedly stumbled upon a cellular pathway that blocked the virus from entering lung cells, SWNS reported.

RESEARCHERS LOCKED FLU PATIENTS IN A HOTEL WITH HEALTHY ADULTS — NO ONE GOT SICK

The data revealed that when a specific human protein called Rab11B was depleted, H3N2 viruses failed to enter human lung cells. H1N1 viruses were completely unaffected.

Using reverse genetics, the team mapped this defect and uncovered a brand-new, H3N2-specific role for Rab11B during viral entry.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

This discovery challenged the scientific assumption that all flu viruses enter cells the same way.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Viruses are like pirates from different countries hijacking someone’s ship,” Bruce said. “Different viruses, like different types of pirates, use different methods to get onboard.”

This discovery challenged the scientific assumption that all flu viruses enter cells the same way. (iStock)

“We had previously thought that all flu viruses used the same way to get into a cell, but we discovered that this is not true,” she went on. “H1N1 and H3N2 need different proteins to get in, and if you get rid of the right protein, a specific virus can’t get in.”

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

While these findings identify a critical cellular pathway for viral entry, the study was conducted using isolated cells, the researchers acknowledged.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Further research is needed to determine whether blocking the protein is safe and effective within a live, complex human respiratory system.

Bruce and the team hope to conduct further research to determine whether this Rab11B-dependency is a fundamental property of H3N2, or if it’s a trait unique to currently circulating flu strains.

Advertisement

Continue Reading

Health

One extra serving of processed meat a day linked to higher cancer risk

Published

on

One extra serving of processed meat a day linked to higher cancer risk

NEWYou can now listen to Fox News articles!

Eating processed meat like ham, sausage and bacon may be linked to a higher risk of certain types of cancer, according to new research.

While health organizations have already confirmed that processed meat can contribute to colon cancer, this study looked closer at cancers in the upper digestive tract, where the link has historically been less clear.

To understand these connections, researchers from the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the world’s largest long-term nutrition and cancer cohorts, tracked the health and diets of 450,112 people across Europe for an average of 14 years. 

FREQUENT HEARTBURN MAY BE A WARNING SIGN OF A MORE DANGEROUS CONDITION, DOCTOR SAYS

Advertisement

The study group included 131,426 men and 318,686 women, according to the study’s press release.

During the follow-up period, 876 people developed stomach cancer and 215 people developed esophageal adenocarcinoma, which is cancer of the tube connecting the mouth to the stomach.

For female participants, eating both processed meat and white meat was linked to an increased risk of developing the disease. (iStock)

Researchers tracked where the stomach cancers grew, separating them into the upper part of the stomach near the throat and the lower part of the stomach.

The researchers also sorted the tumors into two categories based on how the cancer cells appeared under a microscope: intestinal, which forms more organized structures, and diffuse, in which the cells are more scattered throughout the tissue.

Advertisement

BACTERIA IN YOUR MOUTH MAY TRAVEL TO THE GUT AND TRIGGER STOMACH CANCER, RESEARCH FINDS

After adjusting for other lifestyle factors, the researchers found that for every extra 30 grams of processed meat a person ate per day, their overall risk of stomach cancer went up by 9%. Eating that same extra 30 grams a day was also linked to a 13% higher risk of esophageal adenocarcinoma.

A standard single slice of regular deli-sliced ham or lunch meat averages around 28 grams, according to USDA data and nutritional tracking databases.

An extra 20 grams of white meat, such as chicken and turkey, was linked to a 12% higher risk of cancer in the main body of the stomach. (iStock)

An extra 20 grams of white meat, such as chicken or turkey, was linked to a 12% higher risk of cancer in the main body of the stomach, the researchers noted.

Advertisement

The study also revealed differences between men and women. For male participants, only processed meat showed a clear, statistically significant link to a higher risk of stomach cancer. For female participants, however, eating both processed meat and white meat was linked to an increased risk.

CLICK HERE FOR MORE HEALTH STORIES

These findings align with global health benchmarks, particularly those established by the World Health Organization’s International Agency for Research on Cancer.

The agency has long classified processed meat as a known human carcinogen, primarily due to its strong, well-documented links to colorectal cancer.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

However, health organizations have also consistently pointed to a potential, yet less definitive, relationship between these meats and cancers of the stomach.

Eating 30 grams of processed meat a day, or the equivalent to one slice of ham, was linked to a 13% higher risk of esophageal adenocarcinoma. (iStock)

Further scientific investigation is needed to confirm the findings and to account for other underlying risk factors, such as certain stomach infections, which could interact with dietary habits.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

A key limitation of the study is its reliance on self-reported diets, which can sometimes lead to inaccuracies in how participants recall their meat consumption over time, the researchers noted.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The findings were published in the International Journal of Cancer.

Fox News Digital reached out to the researchers requesting comment.

Continue Reading

Health

The Surprising Hormone That Could Make Menopause Weight Loss Easier

Published

on

The Surprising Hormone That Could Make Menopause Weight Loss Easier


Advertisement





The Hormone That Could Make Menopause Weight Loss Easier




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending